JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

Monsters are real

JDRF Canada has a plan to defeat the T1D monster that burdens 300,000 Canadians.

Read More

JDRF celebrates top 10 advances in research

JDRF celebrates top 10 advances in research

Now that 2019 has drawn to a close, we want to take a moment and extend our sincere thanks and appreciation for your support of our efforts in finding cures for type 1 diabetes (T1D) and improving the lives of the more than 300,000 Canadians and their families touched by this disease.


Meet the 2020 Manitoba Lobby Day Delegates!

Meet the 2020 Manitoba Lobby Day Delegates!

We’re so happy to share our 8 finalists with you – meet our 2020 Manitoba Lobby Day Delegates!


#AccessforAll recommendation presented to Ontario's Minister of Finance

#AccessforAll recommendation presented to Ontario's Minister of Finance

She was the youngest person in the room, and her presentation was met with resounding applause from the entire audience. Fourteen-year old Anne Pettigrew made an impressive and compelling presentation at last month’s Ontario pre-budget consultations in Scarborough.


Novel dual-hormone artificial pancreas offers hope for better management of T1D

Novel dual-hormone insulin therapy offers hope for better management of type 1 diabetes

Drs. Ahmad Haidar, Laurent Legault, Michael Tsoukas and Jean-Franҫois Yale are a team of JDRF-funded researchers at McGill University (Montreal) who are the first to test the addition of pramlintide (a synthetic form of amylin, which is a hormone co-secreted with insulin by the healthy pancreas) to ...


A letter to the T1D community from JDRF President and CEO Dave Prowten

A letter to the T1D community from JDRF President and CEO Dave Prowten

I have been blown away by the strength, resilience and generosity demonstrated by you, our JDRF family. I am reminded of how privileged we are to have your continued support. 


T1D and returning to work and school in the wake of the COVID-19 outbreak

T1D and returning to work and school in the wake of the COVID-19 outbreak

We are sharing information that addresses some of the top concerns of the T1D community. Note these responses are not intended to be medical advice, for that—as always—you must consult your own healthcare team.


How is COVID-19 Affecting T1D Research?

How is COVID-19 Affecting T1D Research?

Knowing that many research institutes are closed or have temporarily diverted staff or resources to the COVID-19 pandemic, we are now asking the question: What does this mean for T1D research?


Meet our celebrity lineup for the JDRF House ParT1D for a Cure!

Meet our celebrity lineup for the JDRF House ParT1D for a Cure!

If you haven’t yet heard, you’ve been invited to Canada’s largest virtual house party turning type one diabetes into type none…the JDRF House ParT1D for a Cure, presented by Omnipod!


Advancing cell replacement therapies to treat more people with type 1 diabetes

Advancing cell replacement therapies to treat more people with type 1 diabetes

Dr. Pepper is a promising young Canadian scientist and a new assistant professor in the Department of Surgery at the University of Alberta.


Advocating for insulin pumps in Manitoba

Advocating for insulin pumps in Manitoba

JDRF’s message to the government was straightforward and simple: Manitobans with type 1 diabetes at all ages need access to insulin pumps. 


Lets turn type one into type none